PURPOSE: To estimate the prevalence of active epilepsy in adults in an established demographic surveillance site in rural Tanzania. To describe the clinical characteristics of epilepsy and to estimate the treatment gap in this population. METHODS: A pilot study established that a previously validated screening questionnaire was sensitive for detecting cases of epilepsy in a Kiswahili-speaking Tanzanian population. A door-to-door census of the adult population (total 103,026) used the screening questionnaire to identify possible cases of epilepsy, who were then assessed by a research doctor to establish a diagnosis of epilepsy or otherwise. The prevalence of active epilepsy in this population was estimated with age-standardisation to the WHO standard population. Seizure types and epilepsies were classified according to current recommendations of the International League Against Epilepsy. The treatment gap for epilepsy was estimated based on antiepileptic drug use as reported by cases. RESULTS: Two hundred and ninety-one cases of active epilepsy, all with convulsive seizures, were identified. The age-standardised prevalence was 2.91/1000 adults (95% CI 2.58-3.24); the crude prevalence adjusted for non-response was 3.84/1000 adults (95% CI 3.45-4.20). Focal-onset seizures accounted for 71.5% of all cases identified. The treatment gap was 68.4% (95% CI 63.0-73.7). CONCLUSIONS: This is one of the largest community-based studies of the prevalence of epilepsy in adults conducted in sub-Saharan Africa to date. We identified a lower prevalence than has previously been described in this region. The high proportion of focal onset seizures points to a large burden of acquired, and possibly preventable, epilepsy in this population. A treatment gap of 68.4% confirms that interventions to raise awareness of the treatable nature of epilepsy are warranted in this and similar populations.
PURPOSE: To estimate the prevalence of active epilepsy in adults in an established demographic surveillance site in rural Tanzania. To describe the clinical characteristics of epilepsy and to estimate the treatment gap in this population. METHODS: A pilot study established that a previously validated screening questionnaire was sensitive for detecting cases of epilepsy in a Kiswahili-speaking Tanzanian population. A door-to-door census of the adult population (total 103,026) used the screening questionnaire to identify possible cases of epilepsy, who were then assessed by a research doctor to establish a diagnosis of epilepsy or otherwise. The prevalence of active epilepsy in this population was estimated with age-standardisation to the WHO standard population. Seizure types and epilepsies were classified according to current recommendations of the International League Against Epilepsy. The treatment gap for epilepsy was estimated based on antiepileptic drug use as reported by cases. RESULTS: Two hundred and ninety-one cases of active epilepsy, all with convulsive seizures, were identified. The age-standardised prevalence was 2.91/1000 adults (95% CI 2.58-3.24); the crude prevalence adjusted for non-response was 3.84/1000 adults (95% CI 3.45-4.20). Focal-onset seizures accounted for 71.5% of all cases identified. The treatment gap was 68.4% (95% CI 63.0-73.7). CONCLUSIONS: This is one of the largest community-based studies of the prevalence of epilepsy in adults conducted in sub-Saharan Africa to date. We identified a lower prevalence than has previously been described in this region. The high proportion of focal onset seizures points to a large burden of acquired, and possibly preventable, epilepsy in this population. A treatment gap of 68.4% confirms that interventions to raise awareness of the treatable nature of epilepsy are warranted in this and similar populations.
Authors: Ewan Hunter; Kathryn Burton; Ahmed Iqbal; Daniel Birchall; Margaret Jackson; Jane Rogathe; Ahmed Jusabani; William Gray; Eric Aris; Gathoni Kamuyu; Patricia P Wilkins; Charles R Newton; Richard Walker Journal: Trop Med Int Health Date: 2015-05-26 Impact factor: 2.622
Authors: Clare Bristow; Grace George; Grace Hillsmith; Emma Rainey; Sarah Urasa; Sengua Koipapi; Aloyce Kisoli; Japhet Boni; Grace Anderson Saria; Sherika Ranasinghe; Marcella Joseph; William K Gray; Marieke Dekker; Richard W Walker; Catherine L Dotchin; Elizabeta Mukaetova-Ladinska; William Howlett; Philip Makupa; Stella-Maria Paddick Journal: J Neurovirol Date: 2021-01-11 Impact factor: 2.643
Authors: Gloria Mwanjali; Charles Kihamia; Deodatus Vitalis Conatus Kakoko; Faustin Lekule; Helena Ngowi; Maria Vang Johansen; Stig Milan Thamsborg; Arve Lee Willingham Journal: PLoS Negl Trop Dis Date: 2013-03-14
Authors: Johanna Kellett-Wright; Aidan Flatt; Patrick Eaton; Sarah Urasa; William Howlett; Marieke Dekker; Aloyce Kisoli; Ashanti Duijinmaijer; Jessica Thornton; Judith McCartney; Vanessa Yarwood; Charley Irwin; Elizabeta Mukaetova-Ladinska; Rufus Akinyemi; Bingileki Lwezuala; William K Gray; Richard W Walker; Catherine L Dotchin; Philip Makupa; Stella-Maria Paddick Journal: AIDS Behav Date: 2021-02
Authors: Dominik Stelzle; Veronika Schmidt; Bernard J Ngowi; William Matuja; Erich Schmutzhard; Andrea S Winkler Journal: eNeurologicalSci Date: 2021-06-15